The output from the **Frequently Asked Questions (FAQ)** provides clear and concise information regarding the use of Kesimpta, a medication likely used for a chronic condition. Here’s a breakdown of the key points:
1. **Dosing Schedule**:
– Initial dosing is weekly for three weeks (weeks 0, 1, and 2).
– A skip week follows, after which monthly doses begin on week 5.
2. **Storage Instructions**:
– Kesimpta should be refrigerated and allowed to reach room temperature before use.
3. **Injection Sites**:
– Recommended sites include the front of the thigh and abdomen, with specific guidance on avoiding problematic skin areas.
4. **Preparation for Injection**:
– Important steps include checking expiration, ensuring clarity of the liquid, and proper hygiene before injection.
5. **Injection Procedure**:
– Detailed instructions on how to use the Sensoready Pen, including listening for clicks to confirm the injection process.
6. **Completion of Injection**:
– Confirmation of completion is indicated by a second click and the green indicator’s behavior.
7. **Missed Doses**:
– Guidance on what to do if a dose is missed, emphasizing communication with a healthcare provider for early doses.
8. **Self-Administration**:
– Patients can self-inject after proper training from a healthcare provider.
9. **Disposal**:
– Used pens must be disposed of in an FDA-cleared sharps container.
10. **Tracking Doses**:
– Encouragement to maintain a consistent schedule for ease of tracking.
This FAQ serves as a comprehensive guide for patients using Kesimpta, ensuring they understand how to properly administer the medication and manage their treatment effectively.
Leave a Reply